- Home
- NMRK vs XENE Comparison
NMRK vs XENE Comparison
Compare NMRK & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRK
- XENE
- Stock Information
- Founded
- NMRK 1929
- XENE 1996
- Country
- NMRK United States
- XENE Canada
- Employees
- NMRK N/A
- XENE N/A
- Industry
- NMRK Real Estate
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- NMRK Finance
- XENE Health Care
- Exchange
- NMRK Nasdaq
- XENE Nasdaq
- Market Cap
- NMRK 3.1B
- XENE 3.2B
- IPO Year
- NMRK 2017
- XENE 2014
- Fundamental
- Price
- NMRK $17.53
- XENE $44.44
- Analyst Decision
- NMRK Strong Buy
- XENE Strong Buy
- Analyst Count
- NMRK 5
- XENE 11
- Target Price
- NMRK $19.00
- XENE $53.55
- AVG Volume (30 Days)
- NMRK 1.4M
- XENE 834.7K
- Earning Date
- NMRK 10-30-2025
- XENE 11-03-2025
- Dividend Yield
- NMRK 0.69%
- XENE N/A
- EPS Growth
- NMRK 94.50
- XENE N/A
- EPS
- NMRK 0.59
- XENE N/A
- Revenue
- NMRK $3,160,782,000.00
- XENE $7,500,000.00
- Revenue This Year
- NMRK $19.70
- XENE N/A
- Revenue Next Year
- NMRK $9.58
- XENE $207.88
- P/E Ratio
- NMRK $29.57
- XENE N/A
- Revenue Growth
- NMRK 20.95
- XENE N/A
- 52 Week Low
- NMRK $9.65
- XENE $26.74
- 52 Week High
- NMRK $19.84
- XENE $45.01
- Technical
- Relative Strength Index (RSI)
- NMRK 53.98
- XENE 69.92
- Support Level
- NMRK $15.29
- XENE $39.09
- Resistance Level
- NMRK $17.61
- XENE $42.31
- Average True Range (ATR)
- NMRK 0.64
- XENE 1.46
- MACD
- NMRK 0.11
- XENE 0.43
- Stochastic Oscillator
- NMRK 94.84
- XENE 91.45
About NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.